Company intelligence
HEMOLENS DIAGNOSTICS
to keep you going
About HEMOLENS DIAGNOSTICS
Each year almost 22 million people die from Coronary Artery Disease. It’s now the number one cause of death Worldwide. But the problem lies also in Cardiac Diagnostics. The current diagnostic pathway is very long, expensive, and still not accurate enough. Because of that almost 30% of patients are sent home with their undetected disease. Unnecessary invasive coronary angiographies increase costs and waiting times. Our team consisting of bioengineers, cardiologists, and ICT professionals has created an innovative, non-invasive method of identifying atherosclerosis.
Verified activity
Signals from HEMOLENS DIAGNOSTICS
4 published signals
Presence & Recognition
HEMOLENS DIAGNOSTICS attended ESC Congress 2026 at Booth #35 in Poznań and received 70+ new leads.
Reported by HEMOLENS DIAGNOSTICS
Presence & Recognition
HEMOLENS DIAGNOSTICS participated in the Karpacz conference.
Reported by Bernard Golko
Presence & Recognition
HEMOLENS DIAGNOSTICS presented Hemolens Diagnostics and Cardiolens Viewer® at the ESC Congress 2026 in Munich, featuring speakers Prof. Dariusz Dudek, Chairpersons Adriana Zlahoda-Huzior and Andrzej Kosior.
Reported by HEMOLENS DIAGNOSTICS
Presence & Recognition
HEMOLENS DIAGNOSTICS presented Cardiolens at the ESC Congress 2026 in Munich, engaging clinicians and partners from four continents.
Reported by Bernard Golko